Below is a compact, source-backed reference you can use immediately: top companies with 2024 (or closest available) values, then short bullets for Recent Development, Drivers, Restraints, Regional segmentation, Emerging Trends, Top Use Cases, Major Challenges, Attractive Opportunities and Key factors of market expansion. I cite the most important sources so you can follow up.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Gluten-Free Products market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Gluten-Free Products market.

Read complete report at: https://www.thebrainyinsights.com/report/gluten-free-products-market-13892

Top companies (2024 / closest reported year — company & value)
Many large food companies do not break out a strict “gluten-free” revenue line; where possible I give brand/company figures or the best publicly reported estimate.

Dr. Schär (Eurovo / Schär Group) — €624 million turnover (2024) — specialist global gluten-free leader.

General Mills — major gluten-free portfolio (e.g., Chex, Betty Crocker gluten-free mixes); General Mills total revenue ~$20–22B (FY2024); company is a leading branded player in the category (brand-level gluten-free sales are embedded in overall results).

Kellanova / Kellogg — large consumer cereals & bakery portfolios with gluten-free SKUs; Kellogg/Kellanova consolidated revenue ~$11–14B (2024 estimates) and active in gluten-free aisles.

Conagra Brands — owns gluten-friendly/labelled brands (e.g., some Marie Callender’s, Bird’s Eye/others) and is listed among top market players; company revenue ~$12–14B (2024).

B&G Foods / Udi’s, Boulder Brands (now part of Conagra/others) — historically relevant specialist brands; B&G/Conagra brand portfolios include Udi’s / Glutino lines (varies by corporate ownership).

Enjoy Life Foods (Specialty) — specialist allergy-friendly / gluten-free snacks (now part of Mondelez’s portfolio or strategic partner relationships depending on region).

Schar / Dr. Schär — included above as the largest pure-play gluten-free company; often cited as category leader in Europe and growing globally.

(Market reports also list other notable participants: Barilla (Gluten-Free line), Siete Foods (Latin/US specialist), Amy’s Kitchen (gluten-free ranges), Canyon Bakehouse, King Arthur (gluten-free flours), and many private/niche brands.)

Recent Development
Market estimates for 2024 vary by source (reporting scope differs): Grand View Research estimates ~USD 7.75B (2024) while IMARC reports USD 22.1B (2024) — differences stem from whether prepared foods, ingredients, and all retail channels are included. Use the report that best matches your scope (prepared foods vs entire gluten-free food universe).

Specialist brands (Dr. Schär, Canyon Bakehouse, Enjoy Life) reported strong growth and share gains as larger CPGs launch more gluten-free SKUs and private-label activity increases.

Drivers
Rising diagnosis/awareness of celiac disease & gluten sensitivity and broader health/wellness interest driving trial and repeat purchase.

Retail expansion & product innovation (better taste/texture, frozen and ready meals, bakery replacements) making gluten-free mainstream.

Private-label and mainstream CPG entry expanding price & distribution options, increasing market accessibility.

Restraints
Price premium vs conventional products — gluten-free items are often more expensive, limiting frequent purchase among price-sensitive shoppers.

Cross-contamination & trust issues — consumers with celiac disease demand certified processes; manufacturers face production/labeling costs.

Inconsistent market definitions across reports (some include gluten-free ingredients, others only finished foods), which complicates benchmarking.

Regional segmentation (high level)
North America — one of the largest markets by retail penetration (strong retail, e-commerce, and specialty channels).

Europe — major market with strong specialist brands (Dr. Schär) and extensive retail availability; increasing cross-border exports from EU specialists.

Asia-Pacific — fastest growth potential (rising health awareness and expanding retail); growth depends on local taste localization and supply chains.

LATAM / MEA — emerging adoption in urban centers; growth led by premium/health-conscious consumers and imported specialist brands.

Emerging Trends
Mainstreaming of gluten-free: more shelf space, mainstream CPG launches, and better sensory profiles (taste/texture).

Ready meals & frozen gluten-free — convenience segment expanding rapidly (retail + foodservice).

Private-label growth & price compression — retailers launching low-cost gluten-free lines to capture value shoppers.

Top Use Cases
Celiac disease & diagnosed gluten intolerance — medically-driven purchases (brand loyalty, certified products).

Health-conscious consumers seeking perceived digestive/energy benefits (self-selected).

Convenience meals & bakery replacements for everyday consumption (bread, pasta, snacks, frozen meals).

Major Challenges
Ensuring certified, cross-contamination-free production while scaling volumes cost-effectively.

Balancing price vs quality — lowering price through private label risks alienating premium buyers.

Fragmented reporting & measurement — inconsistent market definitions make benchmarking and investor comparisons noisy.

Attractive Opportunities
Premium frozen and ready-to-eat gluten-free meals (higher ASP, repeat consumption).

Export growth for European specialists (Dr. Schär expanding internationally).

Co-branded / private-label partnerships with large retailers to broaden reach and price tiers.

Key factors of market expansion
Clinical awareness & diagnosis rates (increase addressable medical demand).

Product quality improvements (taste/texture) and innovation (makes repeat purchases mainstream).

Distribution expansion (retail + e-commerce + foodservice) — lowers friction to buy.

Price parity via private label or scale — broadens adoption among price-sensitive shoppers.

Representative sources (pick to follow up)
Grand View Research — Gluten-Free Products Market (market sizing: ~USD 7.75B, 2024).

IMARC Group — Gluten-Free Products Market (USD 22.1B, 2024) (different scope).

Dr. Schär — 2024 turnover €624M (company release).

GMI / Marketinsights summaries — lists of leading corporate players (General Mills, Kellogg/Kellanova, Conagra, Dr. Schär, Enjoy Life).

Future Market Insights / Grand View / Expert Market Research — prepared food subsegments and forecasts.

If you want, I can do one of these now (I’ll generate immediately):

Create a spreadsheet (XLSX) listing the top companies, their 2024 revenues (standardized currencies) and direct source links.

Produce a one-page PowerPoint summarizing the market + top company numbers for stakeholders.

Drill down on a region or company (e.g., Dr. Schär global expansion, General Mills gluten-free SKU performance, or US market breakdown).

Reply with “1”, “2”, or “3 (region/company)” and I’ll generate it right away.